111 filings
Page 3 of 6
8-K
vc15fsi
18 Oct 21
Zai Lab Appoints Scott Morrison
7:38am
8-K
i5wk36wspd
9 Aug 21
Zai Lab Announces Second Quarter 2021
4:06pm
8-K
e29mhlehek5fto7h
24 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
z3c34q9kpkd3bxj
16 Jun 21
Zai Lab and MacroGenics Enter Into Broad Strategic
7:43am
8-K
b04v3m4y4x9racdj
1 Jun 21
Entry into a Material Definitive Agreement
7:30am
8-K
vec6a05
10 May 21
Zai Lab Reports First Quarter 2021 Financial Results
8:55am
8-K
pc8zf
23 Apr 21
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
12:29pm
8-K
wf8amungp
21 Apr 21
Financial Statements and Exhibits
3:00pm
8-K
y0iprawjb0nsavdzxo4
20 Apr 21
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares
9:38pm
8-K
d5so htxqps
19 Apr 21
Zai Lab Announces Proposed Public Offering of American Depositary Shares
4:30pm
8-K
fbxfzqw
13 Apr 21
Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
7:45am
8-K
3f64hdum6p6q2084ps
31 Mar 21
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal
7:32am
8-K
hdiyz5a5x toq1tyiv
1 Mar 21
Zai Lab Announces Financial Results
7:01am
8-K
ujzgwasdrtz0wd3t9
11 Jan 21
Zai Lab Secures Exclusive Right to Develop and Commercialize TPX-0022, Turning
6:52am
8-K
uvr8v4t
6 Jan 21
Zai Lab granted exclusive rights to develop and commercialize efgartigimod in Greater China
4:08pm
8-K
fpgpridmg8n www
4 Jan 21
Other Events
7:27am
6-K
hpto0yby8twmdauv
29 Dec 20
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
7:30am
6-K
opjsdj6q4e89e0lor 85
28 Dec 20
Zai Lab and Cullinan Oncology Announce Strategic
7:30am
6-K
8yxxt
1 Dec 20
Zai Lab Appoints Alan Sandler, M.D., as President, Head of Global Development, Oncology
7:30am
6-K
o1hr4mn
22 Oct 20
Current report (foreign)
8:03am